Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00457847 · ClinicalTrials.gov registry record
Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation
A clinical trial of Lung Transplantation and Primary Graft Dysfunction, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 1,150
- Enrollment target
- 1
- Study location
NCT00457847 is a study of Lung Transplantation and Primary Graft Dysfunction that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,150 participants, above the 240-participant average among 12 other Lung Transplantation trials with a reported enrollment target (379% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00457847, a study of Lung Transplantation and Primary Graft Dysfunction, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 1,150 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary graft dysfunction (PGD) is a severe lung injury that can occur in the days following lung transplant surgery. The purpose of this study is to identify genetic factors that may put someone at risk for developing PGD.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,150 participants |
| Start Date | 2007-02 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00457847
The ClinicalTrials.gov registry entry for NCT00457847 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 240-participant average among 12 other Lung Transplantation trials with a reported enrollment target (379% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Transplantation appearing as the primary indexed condition, and to 0 interventions.
NCT00457847 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00457847 about?
NCT00457847 is a clinical study titled "Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation". Primary graft dysfunction (PGD) is a severe lung injury that can occur in the days following lung transplant surgery. The purpose of this study is to identify genetic factors that may put someone at risk for developing PGD.
What is the current status of trial NCT00457847?
This trial is currently recruiting. The enrollment target is 1,150 participants. The study started on 2007-02. Estimated completion is 2026-06.
What conditions does trial NCT00457847 study?
This clinical trial studies the following conditions: Lung Transplantation, Primary Graft Dysfunction.
Who is sponsoring clinical trial NCT00457847?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00457847 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
RECRUITING · Phase 2
-
Trifecta-Lung cfDNA-MMDx Study
RECRUITING
-
Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
RECRUITING
-
Transplanting Lungs From Uncontrolled Donation After Circulatory Death
RECRUITING · NA
-
This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
RECRUITING · Phase 2
-
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.